Vaccines save millions of lives each year. The development of safe and effective COVID-19 vaccines are a crucial step in helping us get back to doing more of the things we enjoy with the people we love.
Typically,
children are not included in clinical trials until phase 3 trials (in which the
vaccine is given to thousands of people and tested for efficacy and safety)
have been done in adults. This is justifiable in order to ensure we have strong
and compelling safety data of the vaccine in adults before enrolling kids.
Children are a vulnerable research population because they cannot provide
consent, so it is important to minimize the risks to which they are exposed in
research. Like adults and teens who contracted COVID-19, children can spread
the disease when they are asymptomatic. In addition, although children may have
milder symptoms when infected with COVID-19, there are still many cases of
children getting severe lung infections and requiring hospitalization. Other
complications, such as multisystem inflammatory syndrome in children (MIS-C),
may require intensive care or result in long-lasting symptoms. And while
children are less likely to have severe illness initially, they are susceptible
to long COVID symptoms long after initially recovering from their illness.
Vaccines
save millions of lives each year. The development of safe and effective
COVID-19 vaccines are a crucial step in helping us get back to doing more of
the things we enjoy with the people we love. Vaccinating your children can help
protect them and your family and bring the pandemic to an end faster.
references:
No comments:
Post a Comment